Deciphera Pharmaceuticals Inc. was acquired by Ono Pharmaceutical in June 2024. DCPH no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Ono Pharmaceutical, and their dates may not have been updated since.
Clinical trial readout dates for Deciphera Pharmaceuticals Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is March 2027.